Minimally invasive coronary bypass grafting for treating multivessel coronary disease: A single-center prospective pilot study
MICS-CABG, an emerging modality for treating multivessel coronary disease, yields an improved 7- and 30-day physical function than off-pump coronary artery bypass. Moreover, both strategies resulted in similar significant relief from angina over 12 months. A randomized controlled trial is warranted to compare the efficacy of these 2 revascularization strategies. (Prospective Cohort Study on Minimal Invasive Coronary Surgery: NCT04267835).
Authors
- Hang Yang (ORCID: https://orcid.org/0000-0002-3499-1493)
- Liesu Meng (ORCID: https://orcid.org/0000-0003-1985-050X)
- Hui Han (ORCID: https://orcid.org/0000-0002-9973-5888)
- Song Wu (ORCID: https://orcid.org/0000-0003-3504-1630)
- Wei Yang (ORCID: https://orcid.org/0000-0003-0332-2649)
- Yunpeng Ling (ORCID: https://orcid.org/0000-0003-3003-1724)
- Rui Guo (ORCID: https://orcid.org/0000-0002-5294-923X)
- Huiping Zheng
- Hong Zhao (ORCID: https://orcid.org/0000-0002-5253-6638)
- Haibo Feng (ORCID: https://orcid.org/0009-0001-1776-0722)
- Tong Ding (ORCID: https://orcid.org/0009-0003-0204-7304)
- Yichen Gong (ORCID: https://orcid.org/0000-0002-0273-8012)
- Yuanhao Fu
- Zhongqi Cui
Institutions
- Peking University (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- JTCVS Open
- Published
- 2025-05-04
- DOI
- https://doi.org/10.1016/j.xjon.2025.03.030
- Citations
- 2
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- National Natural Science Foundation of China
- Peking University
- Peking University Third Hospital